Hypersensitivity is an exaggerated or inappropriate immune response that can result in tissue damage, inflammation, and various clinical symptoms. It occurs when the immune system reacts excessively to antigens that are usually harmless, such as pollen, certain foods, drugs, or even the body’s own tissues. Understanding the mechanism of hypersensitivity is essential for diagnosing, managing, and treating allergic reactions, autoimmune diseases, and other immune-mediated conditions. This topic explores the types, pathways, and cellular processes involved in hypersensitivity, providing a clear explanation of how the immune system can sometimes cause harm while attempting to protect the body.
Overview of Hypersensitivity Reactions
Hypersensitivity reactions are classified into four main types according to the Gell and Coombs system. These types differ in the immune components involved, the timing of the response, and the clinical manifestations. They are referred to as Type I (immediate), Type II (antibody-mediated), Type III (immune complex-mediated), and Type IV (cell-mediated or delayed-type) hypersensitivity. Each type involves distinct mechanisms and cellular players, making them unique in their pathophysiology and treatment considerations.
Type I Hypersensitivity Immediate Reaction
Type I hypersensitivity, also known as immediate hypersensitivity, is mediated by immunoglobulin E (IgE). When a susceptible individual is exposed to an allergen, B cells produce IgE antibodies that bind to the surface of mast cells and basophils. Upon subsequent exposure to the same allergen, these IgE-coated cells recognize the antigen, triggering the release of histamine, prostaglandins, leukotrienes, and other inflammatory mediators.
This rapid release causes symptoms such as itching, swelling, hives, bronchoconstriction, and, in severe cases, anaphylaxis. Common examples include hay fever, asthma, and food allergies. The mechanism involves
- Activation of Th2 helper T cells that stimulate IgE production.
- IgE binding to high-affinity Fc receptors on mast cells and basophils.
- Cross-linking of IgE by the allergen, resulting in degranulation.
- Release of chemical mediators causing vasodilation, smooth muscle contraction, and increased vascular permeability.
Type II Hypersensitivity Antibody-Mediated Cytotoxicity
Type II hypersensitivity is antibody-mediated and involves IgG or IgM antibodies directed against antigens on the surface of cells or extracellular matrix components. When these antibodies bind to target cells, they can trigger cell destruction through several mechanisms
- Complement activation, which forms membrane attack complexes leading to cell lysis.
- Opsonization, promoting phagocytosis by macrophages and neutrophils.
- Antibody-dependent cellular cytotoxicity (ADCC), where natural killer cells recognize antibody-coated targets and induce apoptosis.
Clinical examples include autoimmune hemolytic anemia, Goodpasture syndrome, and transfusion reactions. The mechanism of hypersensitivity in Type II reactions demonstrates how antibodies that are normally protective can mistakenly target the body’s own cells, resulting in tissue damage.
Type III Hypersensitivity Immune Complex-Mediated
Type III hypersensitivity occurs when antigen-antibody complexes accumulate in tissues, leading to complement activation and inflammation. Unlike Type II, the target is not necessarily the cell itself but the immune complexes that deposit in organs like the kidneys, skin, joints, and blood vessels. The sequence of events includes
- Formation of soluble immune complexes between antigens and IgG or IgM antibodies.
- Deposition of these complexes in tissue, particularly in areas with high blood filtration or slow circulation.
- Activation of the complement system, recruiting neutrophils and other inflammatory cells.
- Tissue damage resulting from enzymatic and oxidative products released by activated immune cells.
Diseases associated with Type III hypersensitivity include systemic lupus erythematosus (SLE), serum sickness, and certain forms of glomerulonephritis. The immune system’s attempt to clear complexes ironically leads to local inflammation and injury.
Type IV Hypersensitivity Delayed-Type Reaction
Type IV hypersensitivity is cell-mediated and does not involve antibodies. Instead, it is driven by sensitized T lymphocytes, primarily CD4+ Th1 cells and CD8+ cytotoxic T cells. This reaction typically develops 24-72 hours after antigen exposure, hence the term delayed-type. The mechanism includes
- Activation of Th1 cells by antigen-presenting cells, leading to cytokine release such as interferon-gamma (IFN-γ).
- Recruitment and activation of macrophages and other inflammatory cells.
- Direct cytotoxicity by CD8+ T cells against target cells expressing the antigen.
- Tissue inflammation and destruction resulting from chronic cellular immune responses.
Examples of Type IV hypersensitivity include contact dermatitis from poison ivy, tuberculin skin test reactions, and chronic transplant rejection. The mechanism highlights how T cells can drive prolonged inflammation without antibodies.
Cellular and Molecular Mediators
Across the different types of hypersensitivity, specific cells and mediators play key roles. Mast cells, basophils, and eosinophils are central in Type I reactions, releasing histamine and other inflammatory molecules. In Types II and III, antibodies (IgG and IgM), complement proteins, and neutrophils mediate tissue injury. Type IV relies heavily on T lymphocytes and macrophages. Cytokines such as interleukins, tumor necrosis factor-alpha (TNF-α), and chemokines orchestrate the inflammatory response and recruit effector cells to the affected tissue.
Clinical Manifestations and Symptoms
The clinical presentation of hypersensitivity depends on the type, the tissue involved, and the severity of the response. Type I reactions often present with urticaria, angioedema, or anaphylaxis. Type II reactions may cause hemolysis, tissue-specific damage, or organ dysfunction. Type III reactions typically involve systemic manifestations such as fever, rash, joint pain, and kidney involvement. Type IV reactions present as localized skin lesions, granulomatous inflammation, or organ-specific tissue damage. Understanding the mechanism of hypersensitivity helps clinicians anticipate and manage these manifestations effectively.
Factors Influencing Hypersensitivity
- Genetic predisposition Some individuals are more prone to hypersensitivity due to HLA gene variants.
- Environmental exposure Repeated exposure to allergens or antigens can sensitize the immune system.
- Immune system status Immunodeficiencies or autoimmune tendencies influence susceptibility.
- Age and gender Certain hypersensitivity reactions are more common in specific age groups or sexes.
Diagnostic and Therapeutic Approaches
Diagnosing hypersensitivity involves identifying the type of reaction, the triggering antigen, and the severity of the response. Laboratory tests may include serum IgE levels, complement assays, antibody titers, and skin testing. For delayed-type hypersensitivity, patch tests and T-cell assays can be useful. Treatment strategies focus on avoiding triggers, managing acute symptoms, and modulating the immune response. Medications such as antihistamines, corticosteroids, immunosuppressants, and monoclonal antibodies are commonly used depending on the type of hypersensitivity.
Prevention and Management
- Avoidance of known allergens or sensitizing agents.
- Use of pharmacologic therapy to control acute symptoms and inflammation.
- Desensitization or immunotherapy for specific allergies.
- Patient education on recognizing early signs of hypersensitivity reactions.
- Monitoring for chronic immune-mediated tissue damage in Type II-IV reactions.
The mechanism of hypersensitivity involves a complex interplay of immune cells, antibodies, and molecular mediators that can result in exaggerated or inappropriate immune responses. By classifying hypersensitivity into four types, clinicians and researchers can better understand how the immune system contributes to tissue injury, inflammation, and disease. Knowledge of cellular mechanisms, mediators, and clinical manifestations is essential for effective diagnosis, treatment, and prevention. Hypersensitivity reactions underscore the delicate balance between protective immunity and harmful overreaction, emphasizing the importance of careful regulation of immune responses for maintaining health.